Perforin Triggers a Plasma Membrane-Repair Response that Facilitates CTL Induction of Apoptosis  by Keefe, Dennis et al.
Immunity, Vol. 23, 249–262, September, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.immuni.2005.08.001
Perforin Triggers a Plasma Membrane-Repair
Response that Facilitates
CTL Induction of Apoptosis
Dennis Keefe,1,2 Lianfa Shi,1,2 Stefan Feske,1,3
Ramiro Massol,1,4 Francisco Navarro,1,2
Tomas Kirchhausen,1,4 and Judy Lieberman1,2,*
1The CBR Institute for Biomedical Research
Boston, Massachusetts 02115
2Department of Pediatrics
3Department of Pathology
4Department of Cell Biology
Harvard Medical School
Boston, Massachusetts 02115
Summary
Perforin delivers granzymes to induce target-cell apo-
ptosis. At high concentrations, perforin multimerizes
in the plasma membrane to form pores. However,
whether granzymes enter target cells via membrane
pores is uncertain. Here we find that perforin at physi-
ologically relevant concentrations and during cell-
mediated lysis creates pores in the target-cell mem-
brane, transiently allowing Ca2+ and small dyes into
the cell. The Ca2+ flux triggers a wounded membrane-
repair response in which internal vesicles, including
lysosomes and endosomes, donate their membranes
to reseal the damaged membrane. Perforin also trig-
gers the rapid endocytosis of granzymes into large
EEA-1-staining vesicles. The restoration of target-cell
membrane integrity by triggering the repair response
is necessary for target cells subjected to cytotoxic T
lymphocyte attack to avoid necrosis and undergo the
slower process of programmed cell death. Thus, the
target cell actively participates in determining its own
fate during cell-mediated death.
Introduction
Perforin (PFN) plays an essential role in the granule ex-
ocytosis pathway of target-cell apoptosis, the main
way cytotoxic T cells (CTL) and natural killer (NK) cells
eliminate virus-infected cells and tumors. Apoptotic
target-cell death is triggered by release of cytotoxic
granule contents into the immunological synapse
formed by CTL binding to its target cell (Stinchcombe
et al., 2001). Cytotoxic granules contain PFN and a
group of serine proteases called granzymes (Gzm) in
a proteoglycan matrix (Lieberman, 2003). PFN delivers
Gzms into the target-cell cytosol. Because multiple
Gzms can independently trigger target-cell apoptosis,
targeted disruption of any one Gzm gene in mice only
modestly affects immune protection. However, there is
only one known delivery molecule. Consequently, mice
deficient in PFN are profoundly immunodeficient and
are unable to protect themselves against viral infection
and tumors (Kagi et al., 1994). Humans with familial
hemophagocytic lymphohistiocytosis due to PFN gene
mutations also have compromised antiviral immunity*Correspondence: lieberman@cbr.med.harvard.edu(Stepp et al., 1999). Although PFN was identified almost
20 years ago and cloned shortly thereafter, the molecu-
lar and cellular basis for PFN activity remains uncertain
(Catalfamo and Henkart, 2003).
At low “sublytic” concentrations, PFN delivers Gzms
to induce apoptosis but causes little cell death on its
own. At higher “lytic” concentrations, PFN induces ne-
crotic death, but not apoptosis, independently of gran-
zymes. Apoptosis, which requires activating a series of
endogenous pathways, occurs slowly over more than
an hour, while necrotic death via PFN occurs within
minutes and preempts the ability to undergo program-
med cell death. PFN-induced necrosis is thought to be
due to loss of plasma membrane integrity. Since CTL
and NK cells kill target cells by apoptosis (Russell et
al., 1980), sublytic concentrations are thought to be
physiologically relevant. The sublytic PFN concentra-
tion that induces 5%–15% necrosis delivers Gzms but
varies between target cells and preparations and must
be carefully titrated for each experiment (Shi et al.,
1992).
PFN shares homology with terminal complement com-
ponents. Because, like complement, PFN multimerizes in
membranes to form pores, PFN was originally hypothe-
sized to deliver Gzms to target cells through plasma
membrane pores (Masson and Tschopp, 1985; Podack et
al., 1985; Sauer et al., 1991; Tschopp et al., 1986; Young
et al., 1986). However, PFN pores seen on electron
micrographs may be too small (%50 nm diameter) to
act as channels for globular molecules like Gzms. More-
over, at sublytic concentrations, even much smaller mole-
cules, such as trypan blue or propidium iodide (PI), do
not diffuse into the cytoplasm of all but a minority of
cells (Kawasaki et al., 2000; Metkar et al., 2002).
The plasma membrane-pore model was questioned
when GzmB was shown to be endocytosed without
PFN (Froelich et al., 1996; Motyka et al., 2000; Pinkoski
et al., 1998; Shi et al., 1997; Trapani et al., 2003). Al-
though apoptosis is not induced until PFN is added,
initial experiments suggested that apoptosis could be
triggered when PFN is added to cells that had pre-
viously endocytosed GzmB (Froelich et al., 1996; Pink-
oski et al., 1998). This result led to a revised model in
which PFN acts to release Gzms from endosomes
(Froelich et al., 1996). This idea was supported by find-
ing that adenovirus and bacterial pore-forming pro-
teins, such as streptolysin, that cause endosomal dis-
ruption can substitute for PFN to introduce Gzms into
target cells (Browne et al., 1999; Froelich et al., 1996;
Pinkoski et al., 1998).
How extracellular PFN acting on the plasma mem-
brane could target Gzm release from membrane bound
intracellular vesicles was unclear. This caused us to re-
examine whether adding PFN to cells, which had pre-
viously endocytosed GzmB, could trigger apoptosis.
Because the Gzms are highly basic (pIsw9–11) and the
plasma membrane negatively charged, GzmB remains
bound to the surface of washed cells, unless cells are
washed with high-ionic-strength buffers (Shi et al.,
2005). By carefully removing all surface bound GzmB,
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endocytosed Gzms. PFN and GzmB must be coendo-
cytosed to release GzmB into the cytosol and trigger
apoptosis.
To begin to understand the molecular basis of PFN
action, we looked at the effect of sublytic and lytic con-
centrations of PFN on cell membranes. At sublytic con-
centrations, PFN damages the plasma membrane to
trigger a transient Ca2+ flux. Cells need to be able to
repair plasma membrane damage that occurs con-
stantly from in vivo mechanical stress. Because cyto-
solic Ca2+ is normally low, while the extracellular milieu
is rich in Ca2+, a rise in cytosolic Ca2+ abovew100 M
triggers a stereotypic, ubiquitous, and rapid damaged
membrane response, sometimes called the “cellular
wound-healing response” because it is activated by
mechanical trauma to the plasma membrane (McNeil
and Steinhardt, 2003). Intracellular vesicles, including
endosomes, lysosomes, and multivesicular bodies, are
mobilized within seconds to donate their membranes to
reseal the damaged plasma membrane (Bi et al., 1995;
McNeil and Steinhardt, 2003; Miyake and McNeil, 1995;
Reddy et al., 2001; Steinhardt et al., 1994). Cellular
wound healing can be detected by finding lysosomal
lumenal membrane proteins, such as CD107a (Lamp-1),
on the cell membrane.
We find that sublytic PFN triggers a rapid damaged
membrane response, which restores plasma membrane
integrity to allow codelivered Gzms to induce the slow
process of apoptosis. When the repair response is in-
hibited, cells treated with GzmB and sublytic PFN are
more likely to die by necrosis than by apoptosis. GzmB
and sublytic PFN treatment is only a model for what
happens during granule-mediated cell death by killer
lymphocytes. Therefore, we were careful to validate our
results using CTL effector cells. Target cells subjected
to CTL attack behave like targets treated with GzmB
and sublytic PFN. They experience a transient Ca2+ flux
and respond to repair the damaged membrane by mo-
bilizing intracellular vesicles. Interfering with the repair
response also shifts the balance of target-cell death
from apoptosis toward necrosis during CTL attack.
Results
A Narrow Window for Perforin Delivery
of Granzymes to Induce Apoptosis
U937 cells were treated with native PFN, purified from
rat NK cells as described (Shi et al., 2000). At PFN con-
centrations above 250 ng/ml, a substantial proportion
of U937 cells take up trypan blue, but their nuclei do
not show morphological features of apoptosis (Figure
1A, data not shown). If GzmB is added with high con-
centrations of PFN, cells still die mostly by necrosis.
This PFN concentration is termed lytic. If the PFN con-
centration is reduced by half to 125 ng/ml, only 9% of
cells take up trypan blue; but if GzmB is added simulta-
neously, 82% of cells become apoptotic. This PFN con-
centration, which delivers Gzms but does not cause
cell death on its own, is called sublytic. If the PFN con-
centration is again reduced by half, PFN no longer ef-
fectively delivers Gzms. Similar results are obtained
with other cells, including K562, HeLa, COS, and B-LCL.
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she sublytic concentration is between 50 and 500 ng/
l, but the concentration varies from cell to cell and
erforin preparation. There is only a 3- to 4-fold varia-
ion between a PFN concentration too low to deliver
zms and a lytic concentration that induces necrosis,
ith the sublytic concentration somewhere in between.
herefore, we have independently determined the sub-
ytic concentration for each experiment as that induc-
ng 5%–15% trypan blue inclusion in the absence of
dded Gzms. By contrast to the narrow window for PFN
ublytic activity, the dose-response curve for GzmB-
nduced apoptosis at a fixed sublytic PFN concentra-
ion increases steadily from no activity at w0.25 g/ml
o reach a plateau at w2 g/ml (data not shown).
erforin Perturbs the Plasma Membrane
ithin seconds of adding sublytic PFN to HeLa cells,
he cell membrane is perturbed with a bubbling appear-
nce caused by the formation of rounded membrane
rotuberances that enlarge and fuse over the first few
inutes (see Movie S1 in the Supplemental Data avail-
ble online with this article). Blebs of up to 3 m diame-
er form focally along the outer membrane. Some blebs
esolve over the 10 min of observation and appear to
e taken up into the cell. In some cells, tubulations that
onnect neighboring cells appear. To visualize the
embrane better, HeLa cells were labeled with the vital
embrane dye DiI and treated with PFN in the pres-
nce of the cell impermeant nuclear dye Sytox green
Figure 1B). Sytox green nuclear staining correlates
ith trypan blue uptake (data not shown) and indicates
oss of membrane integrity and necrotic death. Using a
ublytic PFN concentration, DiI-staining membrane blebs
an be readily seen, but the nuclear dye is largely ex-
luded. A three-dimensional reconstruction of the PFN-
reated cell shows multiple membrane-delimited blebs.
ne of these blebs contains Sytox green, suggesting
hat the membrane may have been temporarily dam-
ged to allow the dye in, but then resealed (see below;
ovie S2). Some of the blebs detach from the cell (Fig-
re 1C). Interestingly, after PFN treatment, DiI also ap-
ears to stain intracellular membranes, consistent with
previous report of plasma membrane exchange in-
uced by PFN (Kawasaki et al., 2000). When a lytic con-
entration of PFN is used, blebs still form, but the mem-
rane barrier is not preserved, allowing Sytox green
nto the cell.
ublytic Perforin Triggers a Transient Ca2+ Flux
n Target Cells
ecause a rapid Ca2+ flux has been reported in target
ells subjected to CTL attack (Poenie et al., 1987) or
reated with purified PFN (Binah et al., 1997) and be-
ause of the membrane perturbations we observed, we
ooked at whether sublytic PFN doses induce a Ca2+
lux. PFN was added at varying concentrations to HeLa
ells preloaded with the Ca2+ indicator fura-2. HeLa
ells require a higher sublytic concentration of PFN
han U937 cells. At 200 ng/ml, a concentration below
he sublytic dose (no PI incorporation and no GzmB
elivery to induce apoptosis [data not shown]), PFN
riggers no Ca2+ influx (Figure 2A). At 320 ng/ml, a
ublytic concentration at which 9% of cells incorporate
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251Figure 1. PFN Has a Narrow Window for De-
livering GzmB to Induce Apoptosis and In-
duces Membrane Perturbations at Sublytic
Concentrations
(A) U937 cells were treated with PFN alone
and assayed for necrosis by trypan blue in-
corporation (open square) or treated with
PFN and GzmB and assayed for apoptosis
by nuclear morphology after DAPI staining
(closed square). At sublytic concentrations,
PFN induces little cell death on its own, but
delivers GzmB to induce apoptosis; at lytic
concentrations, PFN induces necrosis and
adding GzmB does not lead to apoptosis.
The range of PFN concentration effective at
delivering Gzms to induce apoptosis in U937
cells is narrow (>62 ng/ml, <250 ng/ml).
(B) Sublytic PFN induces focal membrane
perturbations, but does not allow dissemina-
tion of small dyes like Sytox green. Fluores-
cence microscopy images of HeLa cells la-
beled with a fluorescent membrane dye (DiI,
red) and treated with buffer alone (left),
sublytic PFN (middle), and lytic PFN (right).
Plasma membrane integrity was assessed
by including the cell impermeant nuclear
stain Sytox green in the assay buffer. A sin-
gle optical section from a Z stack series is
depicted. The three-dimensional Z stack is
shown in Movie S2.
(C) Some membrane blebs (arrows) detach
within minutes of PFN treatment.PI and PFN delivers GzmB, a transient Ca2+ flux lasting
w20–200 s was detected in almost all cells, although
the amount of flux was variable (Figure 2B, Movie S3).
On video images, Ca2+ fluxes were unsynchronized and
in some cases appear to be transmitted from one cell
to another, possibly via the intercellular bridges seen in
Movie S1. At the lytic concentration of 600 ng/ml, PFN
caused a sustained increase in intracellular Ca2+, pre-
sumably due to irreparable damage, as 38% of cells
took up PI (Figure 2C, Movie S4). The increase in intra-
cellular free Ca2+ at the lytic dose resolved in most cells
only when Ca2+ was removed from the perfusing me-
dium. Therefore, the generation and duration of an in-
tracellular Ca2+ flux correlates with PFN function along
its steep dose-response curve—there is no Ca2+ flux
below the sublytic concentration, a transient flux at
sublytic concentrations, and a sustained flux at lytic
concentrations. The transient flux at sublytic PFN con-
centrations suggests that the plasma membrane was
damaged and then could be repaired to restore mem-
brane integrity to exclude extracellular Ca2+ only at
sublytic concentrations. The Ca2+ flux upon PFN treat-
ment was also verified by flow cytometry analysis offluo-3-AM-loaded U937 cells (Figure 2D). Cells ana-
lyzed immediately after exposure to PFN demonstrated
increased intracellular Ca2+ by mean fluorescence in-
tensity (MFI) as the PFN concentration changed from
sublytic to lytic.
Small Molecular Dyes Enter Perforin-Treated Cells,
but Are Contained in Membrane-Proximal Blebs
Because of the pore-forming properties of PFN, the
most likely explanation for the Ca2+ flux in PFN-treated
cells is pore formation at the plasma membrane, allow-
ing extracellular Ca2+ to enter the Ca2+-poor cytosol.
This hypothesis cannot be tested directly by removing
or chelating extracellular Ca2+ because PFN is inactive
in the absence of Ca2+. However, plasma membrane
pores might allow small molecule dyes to enter the cell.
In fact, when cells are treated with sublytic PFN in me-
dium containing trypan blue, uptake of a small amount
of trypan blue into the perturbed membrane bulges is
seen, suggesting a breach in the plasma membrane
(Figure 3A, U937 cells; Figure 3B, HeLa cells). However,
uptake is limited to the blebs and is difficult to see,
suggesting that it is transient. The dye does not dis-
Immunity
252Figure 2. PFN Triggers a Ca2+ Flux
(A–C) Intracellular free Ca2+ increases follow-
ing sublytic or lytic PFN treatment in HeLa
cells stained with fura-2. Ca2+ fluxes were
measured in individual cells treated at time 0
with varying PFN doses. At the lowest dose
(no PI incorporation) (A), no change in Ca2+
was measured until ionomycin was added at
500 s. At the middle sublytic concentration
(<15% PI incorporation) (B), transient Ca2+
fluxes were seen in all cells, while at the
highest lytic dose (35% PI incorporation) (C),
Ca2+ fluxes were sustained until extracellular
calcium was removed by perfusion with cal-
cium-free medium (gray bar). Movie S3 il-
lustrates the Ca2+ fluxes in a low-power im-
age of cells treated with sublytic PFN, while
Movie S4 shows representative cells treated
with a lytic concentration.
(D) Intracellular Ca2+ increases following
PFN treatment of U937 cells stained with
fluo-3 AM. Ca2+ concentration was mea-
sured (bottom) immediately after adding
PFN. Duplicate wells were analyzed for PI in-
corporation (top). The lowest concentration
is sublytic, while the higher concentrations
are lytic.seminate into the cytosol in most cells. Because the
amount of trypan blue taken up into blebs is so small
that it is difficult to visualize by microscopy, we used
more sensitive fluorescent dyes (FITC-dextran, PI) to
also look at uptake of small dyes into U937 cells treated
with sublytic PFN by fluorescence microscopy (Figures
3C and 3D) and into cells treated with rat NK cell gran-
ules, a more physiologically relevant source of PFN, by
flow cytometry (Figure 3E). In cells incubated with me-
dium, few cells take up PI and the background mean
fluorescence intensity (MFI) is w10. However, when
cells are treated with granules, the number of cells that
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to not stain above background for PI is reduced in a
ose-dependent manner and two new populations of
ells are now observed—a dimly staining (MFI w100)
nd a brightly staining (MFI w1000) population. At a
ytic concentration of granules, the dim population dis-
ppears and the brightly staining cells predominate. We
nterpret these data to mean that the dimly staining
ells have taken up the dye and contained it within
lebs, while in the brightly staining cells, the membrane
amage has not been controlled and dye continues to
nflux. Because Ca2+ ions diffuse much more rapidly
han small dyes like trypan blue or PI, Ca2+ fluxes occur
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253Figure 3. Small-Molecule Dyes Enter Blebs
after Sublytic PFN Treatment, but Do Not Ef-
ficiently Gain Access to the Cytosol
(A and B) U937 cells (A) or HeLa cells (B)
were treated with sublytic PFN in medium
containing trypan blue. Trypan blue staining
membrane-associated blebs (black arrows)
are seen in cells that exclude trypan blue
from most of the cytosol. The left panel in (A)
shows control cells not exposed to PFN. In
some fields, a rare necrotic cell that takes up
trypan blue (white arrow) is shown for com-
parison.
(C and D) U937 cells treated with sublytic
PFN in medium containing FITC-dextran (C)
or PI (D) also take up these dyes into blebs
(arrows).
(C) Merged DIC and fluorescence images.
(D) The upper cell has contained PI in a bleb,
the lower cell is a rare necrotic cell in which
PI is not contained and stains the nucleus.
Shown are DIC (left) and fluorescence (mid-
dle) images and their merge (right).
(E) U937 cells, treated with medium or dilu-
tions of purified RNK granules (1/150, 1/100,
1/50), were stained for PI and analyzed for
PIdim and PIbright cells. In PIdim cells, PI is
likely contained in blebs.throughout the cytosol (Figure 2), while negligible
amounts of dye get into the cytosol before the mem-
brane-limited blebs form. Because PI fluorescence is
difficult to detect unless the dye is bound to nucleic
acids, the detection of PI in the blebs suggests the pos-
sibility that cytosolic RNA might be in the blebs. This is
consistent with an earlier, perhaps surprising, report
that the apoptotic blebs produced after PFN and GzmA
treatment contain RNA (Beresford et al., 1999).
PFN Triggers Lysosomal Membrane Fusion
to the Plasma Membrane
When the plasma membrane is disrupted in vivo, cyto-
solic-free [Ca2+] suddenly increases from almost unde-
tectable levels because of high Ca2+ concentrations in
the extracellular milieu. A stereotypic membrane-reseal-
ing response, sometimes called cellular wound healing, is
rapidly triggered when cytosolic [Ca2+] reaches M con-
centrations. The cell responds by fusing lysosomal and
other vesicular membranes to the damaged plasma
membrane (McNeil and Steinhardt, 2003). Because PFN
causes a Ca2+ flux and a Ca2+ flux triggers cellular-
membrane resealing, we looked at whether sublytic
PFN activates a process analogous to wound healing
that might be responsible for maintaining membrane in-
tegrity and the transient nature of the Ca2+ flux. Fusion
of lysosomal membranes to the damaged plasmamembrane can be detected by finding the lumenal lyso-
somal membrane protein Lamp-1 (CD107a) on the cell
surface. PFN-treated cells were costained for PI uptake
and cell-surface Lamp-1. U937 cell targets were ana-
lyzed by flow cytometry (Figure 4A), and HeLa cells
were examined by confocal laser scanning microscopy
(Figure 4B). Diffuse uptake of small dyes, such as PI
or trypan blue, indicates a sustained breach in plasma
membrane integrity that correlates with necrotic death.
At sublytic concentrations of 0.2–0.4 g/ml, cells
acquire cell-surface Lamp-1 expression, identified by
staining without permeabilization. However, bright PI
staining is seen in <10% of cells, compared to back-
ground. Other internal proteins, such as the ER-associ-
ated protein calreticulin, remain intracellular and are not
detected on the cell surface. Lamp-1 can be seen in
discrete patches on the cell membrane, particularly on
the membrane overlying the membrane blebs (Figure
4C). This likely represents discrete fusion events of ly-
sosomes to the plasma membrane. Blebs may form be-
cause the donated membrane causes focal increases
in membrane surface area.
Since a Ca2+ influx is required to trigger fusion of ly-
sosomal membranes to the plasma membrane, we de-
termined whether Lamp-1 is externalized in cells pre-
loaded with the cell-permeant methyl ester BAPTA-AM,
which is converted within cells to the Ca2+ chelator
Immunity
254Figure 4. Sublytic PFN Triggers a Ca2+ Flux-
Dependent Cellular Repair Response
(A and B) PFN induces a wound-healing re-
sponse assessed by Lamp-1 translocation to
the plasma membrane in U937 (A) and HeLa
(B) cells. Cells were stained for Lamp-1
(green) and PI (red) 10 min after adding PFN.
Lamp-1 accumulates on the cell surface in
cells that remain impermeable to PI at lower
PFN concentrations. At the highest lytic con-
centration, more cells become permeable to
PI. Control cells, permeabilized with saponin
in (B), stain for Lamp-1 (green) and PI (red).
(C) Lamp-1 cell-surface staining (green) oc-
curs in discrete patches, particularly on
blebs. Nuclei are DAPI stained (blue).
(D) Chelating intracellular Ca2+ by preloading
cells with BAPTA-AM blocks Lamp-1 translo-
cation. Cells were treated as in (B) with and
without sublytic PFN and stained for Lamp-1,
PI, and calreticulin (Alexa-647, blue). Permea-
bilized control cells stain for all three markers,
while PFN-treated cells not loaded with
BAPTA only show surface Lamp-1 staining.
Single confocal sections at the cell equator
are shown. BAPTA-AM treatment does not
interfere with PFN activity (Figure 5).
(E) Endosomes fuse to plasma membrane at
localized PFN-induced perturbations. HeLa
cells, preloaded with Alexa-488-conjugated
transferrin to label endosomes, were treated
with sublytic PFN for 5 min, and then live cell
fluorescent imaging was performed over 5
min. The left frame shows control cells not
exposed to PFN. The middle and right frame
show sequential still images of the same
bleb at which distinct endosomes docked
and fused their membranes with the plasma
membrane (arrows) (Movie S5).BAPTA (Figure 4D). BAPTA-AM treatment removes free
Ca2+ from the cytosol but does not affect extracellular
Ca2+, required for PFN activity (see below). At sublytic
PFN concentrations, Lamp-1 is externalized in control,
but not in BAPTA-AM-loaded cells. Therefore, BAPTA-
AM treatment inhibits the cellular membrane-repair re-
sponse and can be used to study the effect of this tar-
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iet-cell repair response on PFN- and Gzm-mediated
eath. (Although BAPTA loading does not affect short-
erm cell viability, chelating intracellular Ca2+ may po-
entially interfere with other Ca2+-dependent cellular
rocesses and therefore have unanticipated confound-
ng effects on PFN and Gzm action.)
A variety of membrane bound organelles, including
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255lysosomes, multivesicular bodies, and endosomes, can
participate in plasma membrane resealing (McNeil and
Steinhardt, 2003). To determine whether endosomes
are exocytosed in response to sublytic PFN, HeLa cells
were preloaded with fluorescently labeled transferrin to
label endosomes, treated with PFN, and imaged by
video microscopy (Figure 4E, Movie S5). Transferrin la-
beled the plasma membrane only of PFN-treated cells,
providing evidence for PFN-triggered endosomal fusion
to the plasma membrane. Fusion of transferrin-labeled
endosomes selectively to the plasma membrane over-
lying the perturbed membrane bulges was also seen
during the 5 min observation period only in cells treated
with PFN (Movie S6). Therefore, both endosomes and
lysosomes fuse to the plasma membrane in response
to PFN. These discrete fusion events are likely respon-
sible for the focal areas of high-intensity DiI staining in
Movie S2. These results suggest that plasma mem-
brane damage by sublytic PFN is localized and that do-
nation of vesicular membranes only to damaged areas
may account for the formation of distinct membrane
blebs (Figure 1C, Movies S1, S2, and S5).
Blocking Plasma Membrane Repair by Chelating
Intracellular Ca2+ Enhances PFN-Induced Necrosis
Because PFN multimerization and activity is Ca2+ de-
pendent, we wanted to make sure that PFN activity was
not compromised by chelating intracellular Ca2+ in cells
loaded with BAPTA-AM. BAPTA loading does not affect
short-term cell viability on its own or interfere with ex-
tracellular Ca2+-dependent PFN-induced necrosis, as-
sayed by PI incorporation (Figures 5A and 5B). In fact,
BAPTA-loaded HeLa cells are more susceptible to PFN-
mediated necrosis. While background PI incorporation
in the absence of PFN was slightly different in BAPTA-
loaded cells (control, 5.8% ± 0.4% versus BAPTA-AM-
loaded, 7.5% ± 0.1%), at a sublytic concentration of
PFN (0.2 g/ml), there was almost twice as much cell
death (control, 13.3% ± 3.4% versus BAPTA-AM-
loaded, 22.6% ± 2.1%, p < 0.02). At a lytic concentra-
tion of PFN (0.4 g/ml), there was also significantly
more cell death (control, 29.7% ± 3.0% versus BAPTA-
AM-loaded, 44.9% ± 6.7%, p < 0.03). At this higher con-
centration, the membrane-repair response could miti-
gate against PFN-mediated necrosis in some cells but
could not patch up the damage in many cells.
A distinct dimly PI-staining population was not de-
tected by flow cytometry in treated HeLa cells, as was
seen in U937 cells in Figure 3D. Nonetheless, micro-
scopy showed trypan blue-containing blebs in HeLa
cells (Figure 3B). To look at the effect of Ca2+ chelation
on U937 cells in which we could distinguish PIdim cells,
we analyzed PI incorporation in BAPTA-loaded and
control cells treated with RNK granules, a more physio-
logically relevant reagent than purified PFN. BAPTA
loading slightly increased the numbers of PIdim or
PIbright cells in the absence of granules. After granule
treatment, there was no difference in PI− cells, but
blocking membrane repair via Ca2+ chelation reduced
the proportion of PIdim cells from 37% ± 2% to 21% ±
1% (p < 0.001) and increased the necrotic PIbright cells
from 56% ± 2% to 72% ± 2% (p < 0.001). Therefore,
wound healing allows the cells to avoid necrosis.Blocking the Membrane-Repair Response Reduces
PFN- and GzmB-Mediated Apoptosis
Although inhibiting membrane repair enhanced cell
death, the opposite effect was observed when cells
treated with sublytic PFN and GzmB were assayed for
apoptosis by TUNEL staining (Figures 5D and 5E). Al-
though there was a slight, but significant, increase in
TUNEL staining of BAPTA-AM-loaded cells compared
to control cells following treatment with sublytic PFN
alone (control, 6.8% ± 0.3% versus BAPTA, 10.8% ±
0.9%, p < 0.002), there was dramatically less TUNEL
staining in BAPTA-treated cells than control cells ex-
posed to GzmB and the same amount of PFN (control,
47.5% ± 4.5% versus BAPTA, 14.9% ± 2%, p < 0.001).
Because apoptosis is a slow process that requires w2
hr to induce DNA damage (Shi et al., 2005), TUNEL
staining was performed 2 hr after adding PFN, while
necrosis was measured after 30 min. (It should be
noted that during the additional incubation, some ne-
crotic cells have already disintegrated and are not
counted in the analysis.) We interpret these results to
mean that if cells cannot repair the membrane damage
caused by PFN, they die immediately by necrosis be-
cause the plasma membrane barrier has been irrepara-
bly breached, which precludes triggering the slower
pathway of apoptosis.
PFN Triggers Rapid Endocytosis of GzmB
GzmB is taken up by target cells in the absence of PFN
by endocytosis and, less efficiently, by pinocytosis
(Froelich et al., 1996; Motyka et al., 2000; Pinkoski et
al., 1998; Shi et al., 1997; Trapani et al., 2003; Veugelers
et al., 2004). We also confirmed these findings (Shi et
al., 2005). To determine whether PFN plays a role in
internalizing GzmB, we incubated HeLa cells with
GzmB in the presence or absence of sublytic concen-
trations of PFN. The uptake of GzmB is greatly ac-
celerated and enhanced by PFN (Figure 6A). Within 2
min of adding PFN, GzmB stains prominently in large
vesicles in the cytosol, while without PFN, uptake is
only faintly visible above background until 10 min and
staining remains weaker and is in smaller vesicles. Sim-
ilar results were obtained with U937 and K562 cells (not
shown). Moreover, these GzmB-containing vesicles stain
for the early endosomal marker EEA-1 but not the lyso-
somal marker Lamp-1 (Figure 6B), suggesting that they
do not arise from the membrane blebs induced by PFN.
To quantify the kinetics of GzmB uptake, we used PFN
to deliver GzmB fluorescently conjugated to Alexa 488
(GzmB-488 [Shi et al., 2005]) into U937 cells (Figure 6C
and data not shown). By 3 min in the presence of PFN,
GzmB uptake is completed. Therefore, although Gzms
can be endocytosed independently of PFN, endocyto-
sis is more efficient with PFN.
A Ca2+ Flux Caused by Ionomycin Does Not Activate
Rapid Endocytosis of GzmB
One of the hallmarks of the membrane-repair response
is to stimulate exuberant homotypic and heterotypic
membrane fusion (McNeil and Steinhardt, 2003). It was
therefore possible that triggering the repair response
might drive rapid GzmB internalization. We thus com-
pared the uptake of fluorescent GzmB-488 into U937
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256Figure 5. PFN-Induced Necrosis Is Increased in Cells Loaded with the Ca2+ Chelator BAPTA-AM, but GzmB-Mediated Apoptosis Is Inhibited
(A and B) Inhibiting wound healing by BAPTA-AM treatment of HeLa cells enhances PFN-induced necrosis. Plasma membrane integrity was
assayed by PI incorporation 30 min after incubation at 37oC with PFN. Representative data (A) and means and SD from three independent
experiments (B) are shown. White bars, untreated; black bars, BAPTA-AM treated. p values were calculated from an unpaired Student’s t test.
(C) Inhibiting wound healing in U937 cells enhances PIbright cells and reduces PIdim cells 1 hr after treatment with RNK granules. At 1 hr, cells
have not yet become apoptotic and PIbright cells correspond to necrotic cells (data not shown).
(D and E) Apoptosis, assayed by TUNEL staining, is reduced in BAPTA-loaded HeLa cells treated for 2 hr with GzmB and sublytic PFN.
Triplicate wells were assayed and means ± one SD are depicted in (E). Data in (D) are representative of triplicate samples from two indepen-
dent experiments. White bars, untreated; black bars, BAPTA-AM treated. p values were calculated from an unpaired Student’s t test. Control
cells (no PFN, no GzmB) showed identical TUNEL staining as cells treated with only PFN (not shown).
Perforin Triggers Ca++ Flux and Membrane Repair
257Figure 6. PFN and Ionomycin Both Induce a Cellular Membrane-Repair Response, but Only PFN Enhances GzmB Endocytosis
(A) PFN induces rapid endocytosis of GzmB by HeLa cells into large EEA-1-staining vesicles. Cells, fixed 2 min after exposure to GzmB in
the presence (bottom) or absence (top) of PFN, were stained for EEA-1 and GzmB. Although some GzmB gets into cells independently of
PFN, uptake is enhanced by PFN. GzmB then concentrates in atypical large EEA-1-staining vesicles.
(B) GzmB-containing vesicles stain with EEA-1 but not Lamp-1.
(C) U937 cells were loaded with GzmB-488 in the presence of sublytic PFN (red), 10 M ionomycin (blue), or buffer (gray). PFN, but not
ionomycin, causes rapid endocytosis of GzmB.
(D) Although ionomycin induces a wound-healing response assessed by Lamp-1 cell-surface staining (green; nuclei stained with DAPI [blue]),
even at high sublethal concentrations of ionomycin, GzmB-488 does not enter cells. Cells were also analyzed by flow cytometry (right) for
GzmB-488 uptake 10 min after treatment (ionomycin [circle], PFN [square]).
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258Figure 7. CTL Attack Triggers a Transient Ca2+ Flux and Membrane-Repair Response
(A) A PHA-activated CTL induces a transient Ca2+ flux (green) in a Fura-2-loaded, anti-CD3-coated U937 target cell after a firm synapse is
formed between the effector and target (double arrow). Depicted are the merged DIC and fluorescent images. Approximately 30 s elapse
between each frame.
(B) Intracellular Ca2+ increases in conA-coated K562 cells attacked by CTLs. Fluo-3-loaded K562 cells, labeled with the plasma membrane
dye DiI, were spun briefly with PHA-stimulated CTLs (labeled with Cy5-conjugated anti-CD8) to induce conjugates in the absence or presence
of EGTA to inhibit granule exocytosis. Fluo-3 fluorescence on gated double-positive effector:target cell conjugates indicates an increase in
intracellular Ca2+ in the target only in the presence of extracellular Ca2+. The percent of conjugates containing target cells with elevated
Fluo-3 fluorescence is shown.
(C) CTL attack induces Lamp-1 (green) externalization in HeLa cell targets. ConA-coated HeLa cells were used as targets for PHA-stimulated
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259in target cells subjected to CTL attack. When concana-
CTLs. Pretreating the targets with BAPTA-AM inhibits the repair response to CTL attack. Cells were stained without permeabilization or
fixation. Representative projected Z stack series are shown. CTLs are absent from these images, as nonadherent cells wash off during
staining.
(D) ConA-coated HeLa cells subjected to CTL attack for 2 min develop large EEA-1-staining membrane-proximal vesicles similar to those
detected following PFN loading.
(E) Blocking wound healing by chelating Ca2+ enhances the proportion of necrotic PIbright target cells 1 hr after initiating attack by CMV-
specific CTLs. In this experiment, CTL were labeled with DDAO-SE dye, and the proportion of DDAO-SE− B cell targets that stain brightly
with PI are shown. Data are representative of quadruplicate samples. Numbers indicate the proportion of PIbright DDAO-SE− target cells. There
was no increase in PIbright target cells incubated with an irrelevant HIV reverse transcriptase (RT) peptide after BAPTA treatment.
(F) Model for PFN delivery of Gzms. After CTL granule exocytosis into the immunological synapse (1), PFN multimerizes in the target-cell
membrane to form pores through which Ca2+ and small molecule dyes enter (2), triggering a plasma membrane repair response (3) in which
endosomes and lysosomes fuse with the damaged plasma membrane to reseal it. The fusion produces membrane bound blebs, some of
which may be shed from the cell. PFN also triggers the rapid endocytosis (4) of PFN and Gzms into large endosomes, which may be formed
in part by rapid homotypic fusion of endosomes, in response to the transient Ca2+ flux. We hypothesize that PFN then forms pores in the
endosome membrane, releasing Gzms into the target-cell cytoplasm (5), where they initiate programmed cell death. The model for Gzm
delivery in steps (4) and (5) requires experimental verification.
Ca flux is transient. This likely reflects a wound-heal-cells by sublytic PFN with stimulation of uptake by io-
nomycin. Ionomycin triggers an intracellular Ca2+ flux
by releasing Ca2+ from ER stores and is also known to
trigger the cellular wound healing response (Rodriguez
et al., 1997). We verified this by detecting an increase
in intracellular Ca2+ and Lamp-1 staining by confocal
laser scanning microscopy on unpermeabilized HeLa
cells treated with ionomycin (Figure 6D, data not shown).
However, although it triggers cellular wound healing, io-
nomycin does not enhance GzmB-488 uptake by U937
cells, even at the highest concentrations that do not
cause cell death (Figures 6C and 6D). Therefore, PFN
likely needs to do more than trigger a Ca2+ flux and
wound healing to cause rapid GzmB endocytosis.
Cytotoxic T Lymphocytes Trigger a Ca2+ Flux and
Membrane-Repair Response in Target Cells
Although treating cells with GzmB and sublytic PFN is
a good model to study the steps of apoptosis induction
by CTL, it may not faithfully replicate what happens
when a killer cell destroys a target cell, where PFN and
granzymes are delivered in the spatially limited region
of the immunological synapse. To determine whether
the Ca2+ flux and membrane-repair response observed
after loading cells with PFN is physiologically relevant,
we looked for changes in intracellular Ca2+ and
Lamp-1 externalization in target cells subjected to at-
tack by phytohemagglutinin (PHA)-activated human
CTL. U937 cells coated with anti-CD3 and preloaded
with the Ca2+ indicator dye fura-2 were incubated with
CTL and visualized by digital interference contrast (DIC)
and fluorescence microscopy. Within a few minutes of
forming a firm synapse between the CTL and its target,
a transient target-cell Ca2+ flux was seen (Figure 7A)
Similar results were found by flow cytometry gating on
CTL:target conjugates using concanavalin A (conA)-
coated, Fluo-3-AM-loaded K562 targets incubated with
the same effector cells (Figure 7B). Control experiments
performed with medium containing EGTA showed al-
most no target-cell Ca2+ flux. After CTL attack, target
cells also exhibit the hallmark feature of the plasma
membrane-repair response, cell-surface Lamp-1 stain-
ing (Figure 7C). As expected, Lamp-1 externalization is
inhibited by BAPTA-AM treatment of target cells (Figure
7C). These results show that wound healing also occursvalin A-coated HeLa cells are subjected to CTL attack,
we also detect large EEA-1-staining membrane-proxi-
mal vesicles that resemble the EEA-1-staining GzmB-
containing vesicles seen during PFN loading of GzmB
in Figure 6A (Figure 7D). Moreover, just as inhibiting
wound healing in PFN or granule-loading experiments
enhances target-cell necrosis and inhibits apoptosis,
inhibiting wound healing using BAPTA-AM during CTL
attack also promotes necrosis. If CMV peptide-coated
B cell targets are loaded with BAPTA-AM before initiat-
ing attack by CMV-specific CTLs, necrotic cell death,
assayed by PIbright staining 1 hr later (before apoptosis
has occurred), is significantly enhanced (representative
flow cytometry data, Figure 7E). Although PIbright stain-
ing of CTL-exposed target cells incubated with an irrel-
evant peptide is not changed by BAPTA-AM treatment
(8% ± 1% both with and without BAPTA-AM), PIbright
cells are increased over background from 27% ± 4% to
35% ± 3% (p < 0.0001) in BAPTA-AM-loaded target
cells. Although the difference is small (a 27% increase
in necrosis over background), these data were repro-
duced in two additional independent experiments.
Therefore, the wound-healing response in target cells
subjected to CTL attack contributes to preventing ne-
crosis, recapitulating our results obtained with sublytic
PFN or isolated NK cell granules.
Discussion
In this study, we reexamined the effect of native PFN
on the target-cell membrane. At sublytic concentra-
tions that do not cause cell death on their own, PFN
damages the plasma membrane and induces a tran-
sient Ca2+ flux, which triggers a cellular repair re-
sponse, reminiscent of the cellular wound-healing re-
sponse that reseals holes in injured cell membranes
using pieces of membranes donated by intracellular or-
ganelles. Cells treated with sublytic PFN take up small
amounts of fluid phase dyes, suggesting that at least
small pores are formed at the plasma membrane. These
pores probably cause an influx of Ca2+ from the Ca2+-
rich extracellular milieu to the Ca2+-poor cytosol. How-
ever, fluid phase dyes do not distribute throughout the
cytosol, but remain localized near the plasma mem-
brane in membrane bound blebs. At the same time, the
2+
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and seals the cytosol. During CTL or NK cell death,
the restoration of plasma membrane integrity by the
plasma membrane-repair response protects the cell
from necrosis and allows the Gzms to trigger the slower
process of apoptosis. Since necrotic cells cause an in-
flammatory response while apoptotic cells are recog-
nized and phagocytosed rapidly with less inflammation,
this allows the immune response to maintain its speci-
ficity for targeted cells, minimizing bystander cell dam-
age (Huynh et al., 2002). At lytic PFN concentrations,
the repair response cannot keep up with membrane
damage, the pores are not sealed, and the plasma
membrane barrier is lethally disrupted. However, since
cells targeted by granule-mediated cytolysis die by
apoptosis (Russell et al., 1980), the sublytic concentra-
tion is the physiologically relevant one.
Balaji et al. recently proposed a mechanism by which
CTLs protect themselves from membrane damage by
PFN (Balaji et al., 2002). According to their model,
membrane-associated cathepsin B on the lumenal sur-
face of CTL granules relocalizes to the CTL plasma
membrane during cytotoxic granule exocytosis and
cleaves and inactivates any PFN redirected back to-
ward the killer cell. Since cathepsin B is also on the
membrane of lysosomes, a similar mechanism may be
operating following wound healing to limit continued
target-cell membrane damage by PFN.
Many of the results in this study were obtained by
treating target cells with native PFN. However, this is an
imperfect surrogate for what happens during targeted
delivery of PFN and Gzms by killer cells into the immu-
nological synapse. The local PFN concentration at the
synapse may be higher than what is optimal for loading
by sublytic PFN. We were therefore careful to validate
our results by looking at what happens during CTL at-
tack. During CTL attack, we detected a transient Ca2+
flux and membrane-repair response with characteristic
Lamp-1 externalization in target cells and appearance
of large EEA-1-staining vesicles (Figure 7). Moreover,
the repair response and target-cell apoptosis were in-
hibited by chelating intracellular Ca2+.
Experiments to decipher the mechanism of PFN ac-
tion are tricky because of the narrow window for PFN
to deliver Gzms to induce apoptosis, where a 3- to
4-fold difference separates a subthreshold dose for de-
livering Gzms and a necrotic dose. Measuring the Ca2+
flux is a good way to monitor the effective concentra-
tion of PFN for loading Gzms. If there is no Ca2+ flux,
the concentration is too low to deliver Gzms; if the flux
is transient, the concentration is sublytic; if the flux is
sustained, the cells are killed by necrosis and the con-
centration is too high. A molecular understanding of
how PFN induces a Ca2+ flux is still needed, but likely
depends on the demonstrated ability of PFN to insert
into membranes and multimerize in a Ca2+-dependent
manner to form membrane pores (Masson and Tschopp,
1985; Millard et al., 1984; Sauer et al., 1991; Young et al.,
1986). The existence of pores is verified by the entry of
small molecule dyes into submembrane blebs. These
pores are unlikely to be large enough to allow Gzms
into the cell, since the Gzms are initially found within
EEA-1-staining large vesicles, rather than disseminated
throughout the cytoplasm. It is also unlikely that the
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aarge GzmA-containing vesicles arise from the blebs
ormed during the repair process, since the repair pro-
ess inserts Lamp-1 into the plasma membrane, but
he Gzm-containing vesicles do not stain with Lamp-1.
Therefore, we favor a model (Figure 7F) in which PFN
riggers rapid endocytosis, which causes basic Gzms,
ound to negatively charged glycosaminoglycans on
he plasma membrane by charge (Kurschus et al., 2004;
hi et al., 2005), to be internalized into endosomes.
hese endosomes may fuse with one another because
f the exuberant homotypic and heterotypic membrane
usion characteristic of the membrane-repair response
McNeil and Steinhardt, 2003) to form the large EEA-1-
taining vesicles seen within a minute or two of adding
FN to cells or triggering CTL attack. Membrane fusion
vents likely are also responsible for the membrane
ubbling and intracellular connections seen after treat-
ent with sublytic PFN. Endocytosis is just the first
tep of PFN delivery of Gzms to the cytosol. Within
10 min of PFN treatment, these large vesicles, which
lso stain for PFN, disappear, and Gzms are dissemi-
ated throughout the cell (D.K., L.S., S.F., F.N., R.M.,
.K., and J.L., unpublished data). We hypothesize that
FN within these vesicles damages the vesicular mem-
rane to form large pores that release Gzms into the
ytosol where they activate apoptosis. However, this
iece of the model requires experimental validation.
PFN facilitates the rapid uptake of GzmB (Figure 6)
nto EEA-1-staining vesicles. Although Gzms are endo-
ytosed without PFN (Froelich et al., 1996), this process
s inefficient and unlikely to be physiologically relevant
uring CTL attack when PFN-mediated delivery is com-
leted within a few minutes. A recent study using cells
xpressing dominant-negative mutant dynamin sug-
ests that dynamin-dependent endocytosis is required
o trigger GzmB- and PFN-mediated apoptosis (Veugel-
rs et al., 2004). We confirmed this finding (D.K., L.S.,
.F., F.N., R.M., T.K., and J.L., unpublished data). How-
ver, another study that looked only at cell death did
ot find dynamin to be important (Trapani et al., 2003).
ne way to reconcile these seemingly contradictory
ata would be if dynamin were not required for necro-
ic death by PFN since it involves direct plasma mem-
rane damage, while dynamin-dependent endocytosis
s needed for PFN to deliver Gzms to activate apopto-
is. Because the difference between lytic and sublytic
FN concentration is so small and the activity of stored
FN is not very stable, special care is required in doing
xperiments with PFN to distinguish between its ne-
rotic and Gzm delivery functions.
The membrane-repair response may not be responsi-
le for the rapid PFN-mediated endocytosis of Gzms,
ince ionomycin, another stimulus for the repair re-
ponse, does not enhance GzmB internalization. How-
ver, because ionomycin persists in treated cells, caus-
ng sustained increases in intracellular Ca2+, while
enerally after PFN treatment or membrane resealing
he Ca2+ flux is transient, this question needs to be ex-
mined using other initiators of membrane damage.
he molecular basis for PFN-mediated delivery of
zms into the large endocytic vesicles and from there
o the cytosol still needs to be understood. This study
uggests that although both the original pore model
nd the revised pore-independent endosomolysis model
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261for PFN action may be correct in certain respects, nei-
ther fully explains all of the data. Our revised model,
which incorporates some features of both models, is
consistent with the known data.
The target cell is therefore an active participant in its
own death. The membrane-repair response allows the
target to restore membrane integrity, avoid necrosis,
and undergo apoptosis. Because apoptotic, but not ne-
crotic, cells are rapidly phagocytosed, target-cell mem-
brane repair should reduce inflammation caused by
necrotic cells. This should help maintain immune speci-
ficity, eliminating the intended target cell without caus-
ing harm to bystander cells.
Experimental Procedures
Cell Lines and Reagents
U937 cells were grown in cell-culture medium (RPMI 1640 supple-
mented with 10% FCS, 2 mM glutamine, 2 mM HEPES, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 50 M β-mercaptoethanol).
HeLa cells were grown to roughly 60% confluency in DMEM, sup-
plemented as above, on collagen-coated BIOCOAT slides (BD
Labware, Beverly, MA). CTLs were generated from human PBMCs
treated with 2 g/ml PHA and cultured for 7–20 days in cell-culture
medium containing 600 IU/ml recombinant human IL-2 (a kind gift
of Chiron Oncology). In some experiments, CMV peptide-specific
CTL, generated as described (Martinvalet et al., 2005), was used to
lyse autologous EBV-transformed B cells, pulsed with specific CMV
peptide or control peptide. Cytotoxic granules, GzmB, and PFN
were purified from rat NK cells as described (Shi et al., 2000). Re-
combinant GzmB was purified from baculovirus as reported (Xia et
al., 1998). Rabbit anti-GzmB was produced in the laboratory of the
late A. Greenberg (University of Winnipeg) and has been described
(Shi et al., 2000). Mouse Lamp-1 mAb was from Developmental
Studies Hybridoma Bank (University of Iowa); goat anti-EEA-1 was
from Santa Cruz; rabbit anti-calreticulin was from Stressgen Bio-
technology; Cy5-conjugated anti-CD8 was from Caltag; and anti-
CD3 was purified from the OKT3 hybridoma. ConA and PI were
from Sigma. AlexaFluor 488 (Molecular Probes) was used to label
recombinant GzmB using the manufacturer’s protocol. Sytox green,
DiI, FITC-dextran, BAPTA-AM, fluo-3-AM, fura-2-AM, DDAO-SE,
Alexa-488 conjugated transferrin, and Alexa-conjugated secondary
antibodies were from Molecular Probes.
PFN and GzmB Loading
Cells were equilibrated in cell-loading buffer (HBSS with 10 mM
HEPES, 2 mM CaCl2, 0.4% BSA). PFN and/or GzmB were added
simultaneously at the indicated doses for the indicated times. The
sublytic PFN dose was determined independently for each cell line,
PFN preparation and experiment, as the concentration required to
induce 5%–15% trypan blue or PI uptake (Shi et al., 1992). PI (final
concentration, 2 g/ml) was added during or after PFN incubation
where indicated. For apoptosis assays, cells were incubated for 4
hr at 37°C. For GzmB-488 uptake assays, U937 or HeLa cells were
incubated for the indicated times with GzmB-488 (30 g/ml) in the
presence of cell-loading buffer alone, 10 M ionomycin, or PFN
(0.1 g/ml or indicated concentrations for U937; 0.4 g/ml for
HeLa). U937 cells were washed in 1 mM 5 kDa dextran sulfate to
remove surface bound GzmB before flow cytometry as described
(Shi et al., 2005).
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Supplemental Data include six movies and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.immunity.com/cgi/content/full/23/3/249/DC1/.
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